·Gastroesophageal reflux
disease (GERD) & symptomatic GERD without esophagitis.
·Erosive esophagitis (EE),
long-term management of patients with healed esophagitis to prevent relapse.
·H. pylori eradication to
reduce the risk of duodenal ulcer.
·Short-term treatment of
gastroesophageal reflux disease (GERD) with erosive esophagitis (EE) in adults
and pediatric patients 1 month to 17 years of age, as an alternative to oral therapy when oral esomeprazole
is not possible or appropriate.
·Risk reduction of
re-bleeding of gastric or duodenal ulcers following therapeutic endoscopy for
acute bleeding of gastric or duodenal ulcers in adults.